Puma Biotechnology (PBYI) Return on Invested Capital (2021 - 2026)

Puma Biotechnology's Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed N/A from the prior year.
• Return on Invested Capital was 0.0% for Q1 2026 at Puma Biotechnology, down from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q3 2023 and bottomed at 0.0% in Q1 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2026 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2024 — Return on Invested Capital fell 1 bps — and 2025, when it changed 0 bps.
• Puma Biotechnology's Return on Invested Capital stood at 0.0% in 2022, then jumped by 234 bps to 0.01% in 2023, then sank by 68 bps to 0.0% in 2024, then gained by 26 bps to 0.0% in 2025, then retreated by 3 bps to 0.0% in 2026.
• Business Quant data shows PBYI's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.